What Researchers Did
Researchers conducted the first case study to measure neurocognitive abilities before, during, and after hyperbaric oxygen therapy in a teenage male patient with fetal alcohol syndrome.
What They Found
After 40 hyperbaric treatments, the patient's performance improved in all 6 neurocognitive categories, with word composite scores increasing from 55% to 73% and memory composite scores from 38% to 55%. Reaction time improved from 1.03 to 0.53 seconds, impulse control from 8 to 5, and subjective symptoms diminished by 94%, with verbal memory maintained at 73% six months later.
What This Means for Canadian Patients
This case suggests that hyperbaric oxygen therapy might offer a potential avenue for improving neurocognitive function and reducing symptoms in individuals with fetal alcohol syndrome. While promising, patients and families should discuss this therapy with their healthcare providers, as more research is needed to confirm its broader efficacy and safety.
Canadian Relevance
This specific study has no direct Canadian connection as it was conducted elsewhere.
Study Limitations
As a single case study, these findings cannot be generalized to the broader population of individuals with fetal alcohol syndrome.